» Articles » PMID: 34948918

The Significance of Short Latency in Mesothelioma for Attribution of Causation: Report of a Case with Predisposing Germline Mutations and Review of the Literature

Overview
Publisher MDPI
Date 2021 Dec 24
PMID 34948918
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant mesothelioma is a tumour of the serosal membranes, related to asbestos exposure. Median latency is in the order of 40 years in various registries, but small numbers of cases with shorter latencies have long been reported and often dismissed as unrelated to asbestos exposure. However, emerging data regarding the significance of inherited mutations leading to a predisposition to mesothelioma suggest that the causative effect of asbestos may be associated with shorter latencies in a subset of patients. Here, we describe a male patient with germline mutations in RAD51 and p53 who developed peritoneal mesothelioma 8.5 years after well-documented asbestos exposure and discuss the current literature on the subject. Mesothelioma in situ is now a WHO-accepted diagnosis, but preliminary data reveal a potential lead time of 5 or more years to invasive disease, and this is also a factor which may affect the recording of latency (and potentially survival) in the future.

Citing Articles

Rapid-onset cancer.

Bilger A, Lambert P Tumour Virus Res. 2025; 19:200312.

PMID: 39755235 PMC: 11764593. DOI: 10.1016/j.tvr.2024.200312.


ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment.

Ponce S, Cedres S, Ricordel C, Isambert N, Viteri S, Herrera-Juarez M J Immunother Cancer. 2023; 11(9).

PMID: 37661097 PMC: 10476122. DOI: 10.1136/jitc-2023-007552.

References
1.
Scansetti G, Mollo F, Tiberi G, Andrion A, Piolatto G . Pleural mesothelioma after a short interval from first exposure in the wine filter industry. Am J Ind Med. 1984; 5(4):335-9. DOI: 10.1002/ajim.4700050410. View

2.
Dragani T, Colombo F, Pavlisko E, Roggli V . Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure. Carcinogenesis. 2018; 39(9):1151-1156. DOI: 10.1093/carcin/bgy089. View

3.
Carbone M, Harbour J, Brugarolas J, Bononi A, Pagano I, Dey A . Biological Mechanisms and Clinical Significance of Mutations in Human Cancer. Cancer Discov. 2020; 10(8):1103-1120. PMC: 8006752. DOI: 10.1158/2159-8290.CD-19-1220. View

4.
Marinaccio A, Binazzi A, Cauzillo G, Cavone D, De Zotti R, Ferrante P . Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer. 2007; 43(18):2722-8. DOI: 10.1016/j.ejca.2007.09.018. View

5.
Liu G, Cheresh P, Kamp D . Molecular basis of asbestos-induced lung disease. Annu Rev Pathol. 2013; 8:161-87. PMC: 3900296. DOI: 10.1146/annurev-pathol-020712-163942. View